SHG:688319 - Chengdu Olymvax Biopharmaceuticals Inc

Chengdu Olymvax Biopharmaceuti
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2017 Q4	2018 Q4	2019 Q1	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	62.16% -	57.86% -6.9%	57.69% -0.3%	57.69% 0%	53.11% -7.9%	53.11% 0%	50.31% -5.3%
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	17.33% 12.8%	19.19% 10.7%	22.16% 15.5%	16.91% -23.7%	17.55% 3.8%	12.29% -29.9%	4.85% -60.5%	6.64% 36.8%	4.39% -33.8%	3.15% -28.2%	3.54% 12.2%	-2.46% -
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	94.41% -0.9%	93.73% -0.7%	93.93% 0.2%	93.72% -0.2%	93.69% 0.0%	93.8% 0.1%	92.86% -1.0%	92.28% -0.6%	93.1% 0.9%	93.02% -0.1%	93.55% 0.6%	93.96% 0.4%
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	18.84% 3.5%	19.55% 3.8%	22.48% 15.0%	17.05% -24.1%	20.21% 18.6%	15.84% -21.6%	11.05% -30.3%	12.89% 16.7%	10.87% -15.6%	6.24% -42.6%	6.47% 3.8%	-1.42% -
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	377.74M 6.5%	404.79M 7.2%	487.15M 20.3%	477.25M -2.0%	550.74M 15.4%	573.16M 4.1%	547.48M -4.5%	560.82M 2.4%	547.97M -2.3%	529M -3.5%	496.12M -6.2%	500.05M 0.8%
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	1.03B 63.3%	1.08B 4.7%	1.21B 12.2%	1.21B 0.0%	1.3B 7.5%	1.36B 4.6%	1.48B 8.5%	1.4B -5.2%	1.48B 5.7%	1.51B 1.7%	1.61B 7.0%	1.59B -1.1%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	253.87M 8.2%	266.67M 5.0%	367.22M 37.7%	373.71M 1.8%	425.6M 13.9%	475.52M 11.7%	587.02M 23.4%	509.59M -13.2%	558.68M 9.6%	565.89M 1.3%	681.84M 20.5%	686.45M 0.7%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	778.16M 95.8%	813.62M 4.6%	844.66M 3.8%	838.59M -0.7%	877.18M 4.6%	887.06M 1.1%	881.63M -0.6%	883.96M 0.3%	911.99M 3.2%	924.62M 1.4%	916.91M -0.8%	895.13M -2.4%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	21.49M 68.3%	-	39.96M -	-	12.57M -	-	-24.55M -	-	-11.12M -	-	44M -	-
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	50.16M -21.5%	56.18M 12.0%	86.45M 53.9%	60.55M -30.0%	431.83M 613.2%	134.42M -68.9%	239.27M 78.0%	185.14M -22.6%	409.47M 121.2%	336.17M -17.9%	261.11M -22.3%	291.36M 11.6%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	431.83M 613.2%	134.42M -68.9%	239.27M 78.0%	185.14M -22.6%	409.47M 121.2%	336.17M -17.9%	261.11M -22.3%	291.36M 11.6%	264.76M -9.1%	343.73M 29.8%	355.53M 3.4%	286.78M -19.3%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-17.87M -	-22.2M -	-29.75M -	-68.14M -	-95.24M -	-190.66M -	-225.24M -	-205.97M -	-204.62M -	-95.05M -	-125.88M -	-175.22M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	65.46M 20.2%	-	107.96M -	-	96.65M -	-	26.58M -	-	21.98M -	-	11.44M -	-
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.179 20.1%	0.205 14.4%	0.28 36.6%	0.208 -26.0%	0.241 16.0%	0.174 -27.7%	0.066 -62.3%	0.092 40.1%	0.059 -35.4%	0.041 -30.6%	0.043 5.1%	-0.03 -
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	11.56% -21.4%	13.05% 12.8%	17.68% 35.5%	13.06% -26.1%	11.68% -10.6%	8.29% -29.0%	3.08% -62.8%	4.32% 40.4%	2.69% -37.7%	1.84% -31.6%	1.95% 6.0%	-1.38% -
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	8.5% -13.4%	9.42% 10.8%	11.65% 23.7%	8.75% -24.9%	8.28% -5.4%	5.77% -30.3%	1.98% -65.8%	2.85% 44.2%	1.73% -39.3%	1.16% -32.8%	1.14% -2.3%	-0.82% -